View All Key Stats
VSTM Key Stats
| Income Statement | |
| Revenue (TTM) | -- |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (TTM) | -1.24 |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Net Income (TTM) | -46.02M |
| Profitability | |
| Gross Profit Margin (Quarterly) | -- |
| Profit Margin (Quarterly) | -- |
| Dividend | |
| Dividend Yield (Forward) | Upgrade |
| Dividend Yield (TTM) | 0 |
| Price and Valuation | |
| Market Cap | 153.33M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| PS Ratio (TTM) | -- |
| PE Ratio (TTM) | -- |
| Price to Book Value | 3.179 |
| Other | |
| Beta (5Y) | Upgrade |
| Debt to Equity Ratio (Quarterly) | -- |
| Free Cash Flow (Quarterly) | -14.48M |
| Return on Equity (TTM) | -- |
View All VSTM News
VSTM News
-
WireHeadlineTime (ET)
-
MT Newswires10/17 10:14
-
Business Wire10/17 07:00
-
MT Newswires10/11 17:49
-
MT Newswires10/11 16:24
-
Business Wire10/11 16:01
-
Business Wire09/22 07:15
-
PR Newswire09/20 09:00
-
SA Breaking News09/08 11:00
-
Yahoo09/07 08:00
-
SA Breaking News09/06 17:38
View All Events
VSTM Events
| Date | Type | Description |
|---|---|---|
| 05/17/2017 | Misc | Verastem Inc Annual General Meeting in 2016 |
| 05/10/2017 | Earnings | Verastem Inc First Quarter Earnings Results in 2017 |
| 03/23/2017 16:30 EDT | Misc | Verastem Inc Fourth Quarter Earnings Conference Call in 2017 |
| 03/23/2017 | Earnings | Verastem Inc Fourth Quarter Earnings in 2017 Release |
| 02/14/2017 09:00 EDT | Misc | Verastem Announces Reduction of Workforce |
| 12/03/2016 | Misc | Verastem Inc Annual General Meeting in 2015 |
| 11/07/2016 | Earnings | Verastem Inc Third Quarter Earnings Results in 2016 |
VSTM Fundamentals
Income Statement View Statement
VSTM Ratings
- Y-Rating Upgrade
- Value Score Upgrade
- Fundamental Score Upgrade
- Valuation (Hist. Mult.) Upgrade
- Y-Rating Report Download
Advertisement
VSTM One Page Reports
- One Page Report Download
VSTM Analyst Coverage
| Consensus Recommendations | |
| Buy Recommendations | Upgrade |
| Outperform Recommendations | Upgrade |
| Hold Recommendations | Upgrade |
| Underperform Recommendations | Upgrade |
| Sell Recommendations | Upgrade |
| Consensus Recommendation | Upgrade |
| Target Price | |
| Price | 4.145 |
| Price Target | Upgrade |
Edit
Profile
- URL: http://www.verastem.com
- Investor Relations URL: http://phx.corporate-ir.net/phoenix.zhtml?c=250749&p=irol-irhome
- HQ State/Province: Massachusetts
- Sector: Healthcare
- Industry: Biotechnology
- Equity Style: Small Cap/Value
- Next Earnings Release: N/A
- Last Earnings Release: May. 10, 2017
- Next Ex-Dividend Date: N/A
- Last Ex-Dividend Date: N/A
- Description: Verastem Inc is a biopharmaceutical company engaged in discovering and developing drugs to improve outcomes for patients with cancer. Its product candidates include duvelisib and defactinib (VS-6063).
VSTM Comparables
EditVSTM Excel Add-In Codes
- Name: =YCI("VSTM","name")
- Description: =YCI("VSTM","description")
- Sector: =YCI("VSTM","sector")
- Industry: =YCI("VSTM","industry")
- Est. Current Fiscal Year End: =YCI("VSTM","fye")
To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.
Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.
Other VSTM Resources
- 13F Filings Whale Wisdom
- Call Transcripts Seeking Alpha
- Insider Trading Morningstar
- Institutional Ownership Nasdaq
- SEC Filings SEC
- VSTM Tweets Stocktwits
Advertisement
